Last reviewed · How we verify

NCT05962086

Determining Developmental and Clinical Markers Affecting Urinary Function of Children With Spinal Dysraphism

Status unknown Last updated 27 July 2023
What this trial tests

trial in Spinal Dysraphism in 1,500 participants. Status unknown.

Timeline
22 October 2022
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorSeoul National University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,500
Start date22 October 2022
Primary completion31 December 2024
Estimated completion31 December 2024
Sites6 locations across South Korea

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Under 10, any sex, with Spinal Dysraphism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To identify developmental and clinical biomarkers that affect urinary incontinence at the ages of 5, 7, and 10 according to different neuro-urological clinical factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05962086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing